Pazopanib Tablet
Product Images NDC 60505-4779

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pazopanib (NDC 60505-4779). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

A Kaplan-Meier curve showing progression-free proportion over time in months for Pazopanib versus placebo groups. The plot compares the two groups' progression-free rates, indicating statistical measures including median progression-free months, hazard ratio, confidence interval, and p-value.*

FDA Label Image

Figure2.jpg (Figure2)

A Kaplan-Meier survival curve chart comparing the proportion of patients progression-free over time (months) between Pazopanib and placebo groups. The Pazopanib group displays a higher progression-free proportion over time with a median of 4.6 months versus 1.6 months for placebo.*

FDA Label Image

Bottlelabel120.jpg (Bottlelabel120)

Label for Pazopanib Tablets 200 mg, oral tablets, manufactured by Apotex Corp. The label states the package contains 120 tablets with NDC 60505-4779-7. It includes storage instructions, a caution not to use if the seal is broken or missing, and directions to see accompanying prescribing information. The label also provides a pharmacist instruction to dispense with a medication guide available online.*

FDA Label Image

Bottlelabel500.jpg (Bottlelabel500)

Pazopanib 200 mg tablets packaging label by Apotex Corp. The label indicates 500 tablets per bottle with NDC 60505-4779-5. It includes storage instructions, a note not to use if the seal is broken or missing, and a pharmacist dispensing guide URL. Manufacturer details are listed as Apotex Inc., Canada, with manufacturing for Apotex Corp., Florida.*

FDA Label Image

Structuure.jpg (Structure)

Chemical structure of Pazopanib hydrochloride, showing the molecular arrangement of atoms including sulfonamide, pyrimidine, and indazole moieties with methyl substitutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.